Oncosil Medical Ltd has released a press release.
OncoSil achieves first commercial sale
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from OncoSil Medical
- Positive PanCO trial update on resected cohort
- Receipt of $2.8m R&D Tax Incentive Refund
- Investor Update
- OncoSil receives Malaysian regulatory approval
- Preliminary Final Report - Appendix 4E Announcement
Later from OncoSil Medical
- OncoSil receives Swiss regulatory approval
- Termination of Mr Daniel Kenny as Chief Executive Officer
- OncoSil FY21 half yearly review
- Appointment of Chief Executive Officer
- Appendix 4C - quarterly
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical